表紙
市場調查報告書

先進創傷護理的前20名公司分析:2020年

Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies

出版商 Visiongain Ltd 商品編碼 915073
出版日期 內容資訊 英文 129 Pages
商品交期: 最快1-2個工作天內
價格
先進創傷護理的前20名公司分析:2020年 Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies
出版日期: 2019年09月30日內容資訊: 英文 129 Pages
簡介

2018年的全球先進創傷護理的市場估計為92億美元。

本報告提供全球先進創傷護理的市場調查,市場定義和概要,各地區的需求趨勢,市場成長的各種影響因素分析,主要20家公司的排行榜,主要20家公司的財務展望,產品系列,策略性展開等分析彙整。

第1章 報告概要

第2章 簡介:先進創傷護理市場

  • 市場定義
  • 市場區隔
    • 治療區分
      • 傳統照護
      • 先進創傷護理
    • 皮膚補充
      • 皮膚替代治療
      • 膠原蛋白治療
      • 細胞治療
    • 設備
      • 傷口負壓治療 (NPWT)
      • 超音波
  • 地區需求
    • 南北美洲
    • 歐洲
    • 亞太地區

第3章 全球先進創傷護理市場

  • 市場概要
  • 產業趨勢、預測
  • 成長推動因素、課題、市場機會

第4章 主要20家公司的地位

  • 企業排行榜
  • 全球先進創傷護理市場預測

第5章 前20名公司

  • Smith & Nephew Plc.
  • Acelity (KCI and Systagenix)
  • Molnlycke Health Care AB
  • ConvaTec Group Plc
  • Coloplast A/S
  • 3M Company
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Generex Biotechnology Corp.
  • Hill-Rom Holdings, Inc.
  • Hollister, Inc.
  • Integra LifeSciences Holdings Corporation
  • Lohmann & Rauscher GmbH & Co. Kg
  • Medline Industries, Inc.
  • Medtronic PLC
  • Organogenesis Inc.
  • PAUL HARTMANN AG
  • Celularity, Inc.
  • Johnson & Johnson

第6章 SWOT分析

第7章 總論

  • 持續的革新、強力的研發產品線
  • 與其他的治療藥比較的高效率性
  • 寡占市場
  • 前20名公司和收益

附錄

目錄
Product Code: PHA0527

The global advanced wound care market was valued at $9.2bn in 2018. The largest segment of the advanced wound care market will continue to be active wound care throughout the forecast period. However, this segment will continue to lose market shares to wound care devices and wound care biologics sectors, from 55.2% in 2019 to 38.9% in 2029.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 129-page report you will receive 121 charts - all unavailable elsewhere.

The 129-page report provides clear detailed insight into the leading 20 companies in the advanced wound care market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Advanced Wound Care Market forecast from 2019-2029

Forecast of the Global Advanced Wound Care Market by region:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • RoW

Our study discusses the selected leading companies that are the major players in the global advanced wound care market:

  • 3M Company
  • Acelity L.P. Inc.
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Celularity, Inc.
  • Coloplast A/S
  • ConvaTec Group plc
  • Generex Biotechnology Corp.
  • Hill-Rom Holdings, Inc.
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Lohmann & Rauscher GmbH & Co. Kg
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mölnlycke Health Care
  • Organogenesis
  • PAUL HARTMANN AG
  • Smith & Nephew

This report provides a SWOT analysis of the advanced wound care market.

This report also discusses factors that drive and restrain the market, as well as opportunities in the advanced wound care market.

Visiongain's study is intended for anyone requiring commercial analyses for the top 20 advanced wound care companies. You find data, trends and predictions.

Buy our report today Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Overview of the Global Advanced Wound Care Market
  • 1.3 Benefits of This Report
  • 1.4 Report Structure
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 Primary Research
    • 1.6.2 Secondary Research
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to the Advanced Wound Care Market

  • 2.1 Advanced Wound Care Market Definition
    • 2.1.1 Definition of Wound
    • 2.1.2 Types of Wound
  • 2.2 Advanced Wound Care Market Segmentation
    • 2.2.1 Advanced Wound Care Market by Therapy
      • 2.2.1.1 Traditional wound care
      • 2.2.1.2 Advanced Wound Care
    • 2.2.2 Advanced Wound Care Market by Biologics
      • 2.2.2.1 Skin Replacement Therapies
      • 2.2.2.2 Collagen-Based Therapies
      • 2.2.2.3 Cell-Based Therapies
    • 2.2.3 Advanced Wound Care market by Devices
      • 2.2.3.1 Negative Pressure Wound Therapy (NPWT)
      • 2.2.3.2 Ultrasound for Wound Therapy
  • 2.3 Demand for Advanced Wound Care in Regional Markets
    • 2.3.1 Americas Advanced Wound Care Market Overview - 2018
    • 2.3.2 Europe Advanced Wound Care Market Overview- 2018
    • 2.3.3 Asia-Pacific Advanced Wound Care Market 2018

3. Global Advanced Wound Care Market, 2018

  • 3.1 Global Advanced Wound Care Market 2018 Overview
  • 3.2 The World Advanced Wound Care Market: Industry Trends, 2018-2029
  • 3.3 Drivers and Challenges for the Global Advanced Wound Care Market
    • 3.3.1 Drivers
      • 3.3.1.1 Increase in Aging Population:
      • 3.3.1.2 Lifestyle Factors
      • 3.3.1.3 Growing Incidence of Diabetes, Ulcers and Chronic Wounds
      • 3.3.1.4 Technological Advancements and Government Initiatives
    • 3.3.2 Challenges
      • 3.3.2.1 High Cost Procedures
      • 3.3.2.2 Disparity in Reimbursements
      • 3.3.2.3 Reluctance to Accept New Technologies
    • 3.3.3 Opportunities
      • 3.3.3.1 Significant Growth Opportunities in Asia-Pacific and Developing Countries
      • 3.3.3.2 Healthy Growth in the Active Wound Care Market

4. Leading 20 Companies Positioning in the Advanced Wound Care Market

  • 4.1 Leading 20 Companies Ranking in the Advanced Wound Care Market
  • 4.2 Global Advanced Wound Care Market Forecast, 2018-2029

5. Top 20 Advanced Wound Care Companies

  • 5.1 Smith & Nephew Plc. Overview
    • 5.1.1 Smith & Nephew Plc. Financial Outlook
    • 5.1.2 Smith & Nephew Plc Product Portfolio
    • 5.1.3 Smith & Nephew Plc Strategic Developments
  • 5.2 Acelity (KCI and Systagenix) Overview
    • 5.2.1 Acelity L.P. Inc. Financial Outlook
    • 5.2.2 Acelity L.P. Inc. Product Portfolio
    • 5.2.3 Acelity L.P. Inc. Strategic Developments
  • 5.3 Mölnlycke Health Care AB Overview
    • 5.3.1 Mölnlycke Financial Outlook
    • 5.3.2 Mölnlycke Product Portfolio
    • 5.3.3 Mölnlycke Strategic Developments
  • 5.4 ConvaTec Group Plc Overview
    • 5.4.1 ConvaTec Group Plc Financial Outlook
    • 5.4.2 ConvaTec Group Plc Product Portfolio
    • 5.4.3 ConvaTec Group Plc Strategic Developments
  • 5.5 Coloplast A/S Overview
    • 5.5.1 Coloplast A/S Financial Outlook
    • 5.5.2 Coloplast A/S Product Portfolio
    • 5.5.3 Coloplast A/S Strategic Developments
  • 5.6 3M Company Overview
  • 5.6. 3M Company Financial Outlook
    • 5.6.2 3M Company Product Portfolio
    • 5.6.3 3M Company Strategic Developments
  • 5.7 B. Braun Melsungen AG Overview
    • 5.7.1 B. Braun Melsungen AG Financial Outlook
    • 5.7.2 B. Braun Melsungen AG Product Portfolio
    • 5.7.3 B. Braun Melsungen AG Strategic Developments
  • 5.8 BSN Medical GmbH Overview
    • 5.8.1 BSN Medical GmbH Financial Outlook
    • 5.8.2 BSN Medical GmbH Product Portfolio
    • 5.8.3 BSN Medical GmbH Strategic Developments
  • 5.9 Cardinal Health, Inc. Overview
    • 5.9.1 Cardinal Health, Inc. Financial Outlook
    • 5.9.2 Cardinal Health, Inc. Product Portfolio
    • 5.9.3 Cardinal Health, Inc. Strategic Developments
  • 5.10 Generex Biotechnology Corp. Overview
    • 5.10.1 Generex Biotechnology Corp.Financial Outlook
    • 5.10.2 Generex Biotechnology Corp. Product Portfolio
    • 5.10.3 Generex Biotechnology Corp. Strategic Developments
  • 5.11 Hill-Rom Holdings, Inc. Overview
    • 5.11.1 Hill-Rom Holdings, Inc.Financial Outlook
    • 5.9.2 Hill-Rom Holdings, Inc. Product Portfolio
  • 5.11.3 Hill-Rom Holdings, Inc. Strategic Developments
  • 5.12 Hollister, Inc. Overview
    • 5.12.1 Hollister, Inc. Financial Outlook
    • 5.12.2 Hollister, Inc. Product Portfolio
  • 5.13 Integra LifeSciences Holdings Corporation Overview
    • 5.13.1 Integra LifeSciences Holdings Corporation Financial Outlook
    • 5.9.2 Integra LifeSciences Holdings Corporation Product Portfolio
    • 5.13.3 Integra LifeSciences Holdings Corporation Strategic Developments
  • 5.14 Lohmann & Rauscher GmbH & Co. Kg Overview
    • 5.14.1 Lohmann & Rauscher GmbH & Co. Kg Financial Outlook
    • 5.14.2 Lohmann & Rauscher GmbH & Co. Kg Product Portfolio
    • 5.14.3 Lohmann & Rauscher GmbH & Co. Kg Strategic Developments
  • 5.15 Medline Industries, Inc. Overview
    • 5.15.1 Medline Industries, Inc. Financial Outlook
    • 5.15.2 Medline Industries, Inc. Product Portfolio
  • 5.16 Medtronic PLC Overview
    • 5.16.1 Medtronic PLC Financial Outlook
    • 5.16.2 Medtronic PLC Product Portfolio
    • 5.16.3 Medtronic PLC Strategic Developments
  • 5.17 Organogenesis Inc. Overview
    • 5.17.1 Organogenesis Inc.Financial Outlook
    • 5.17.2 Organogenesis Inc. Product Portfolio
    • 5.17.3 Organogenesis Inc. Strategic Developments
  • 5.18 PAUL HARTMANN AG Overview
    • 5.18.1 PAUL HARTMANN AG Financial Outlook
    • 5.18.2 PAUL HARTMANN AG Product Portfolio
  • 5.19 Celularity, Inc.Overview
    • 5.19.1 Celularity, Inc. Financial Outlook
    • 5.19.2 Celularity, Inc. Product Portfolio
    • 5.19.3 Celularity, Inc. Strategic Developments
  • 5.20 Johnson & Johnson Overview
    • 5.20.1 Johnson & Johnson Financial Outlook
    • 5.5.2 Johnson & Johnson Product Portfolio

6 SWOT Analysis of the Global Advanced Wound Care Market

  • 6.1 Strengths
  • 6.2 Weaknesses
  • 6.3 Opportunities
  • 6.4 Threats

7. Conclusion

  • 7.1 Continuous Innovation and a Strong R&D Pipeline
  • 7.2 Higher Effectiveness Compared with Other Treatments
  • 7.3 An Oligopolistic Market
  • 7.4 Top 20 Companies and Revenue

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 2.1 The Global Advanced Wound Care Market Revenue Forecast ($bn), 2018-2029
  • Table 2.2 The North America Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 2.3 The Europe Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 2.4 Asia-pacific Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 4.1 Companies Profiled in this Report and Country HQ
  • Table 4.2 Global Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
  • Table 5.1 Smith & Nephew Plc.: Key Facts, 2019
  • Table 5.2 Smith & Nephew Plc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.3 Smith & Nephew Plc.: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.4 Smith & Nephew Plc.: Advanced Wound Management Revenue ($million), AGR (%) 2016-2018
  • Table 5.5 Smith & Nephew Plc.: Advanced Wound Management Product Revenue ($million) and Revenue Shares (%), 2018
  • Table 5.6 Smith & Nephew Plc.: Strategic Developments, 2015-2019
  • Table 5.7 Acelity L.P. Inc.: Key Facts, 2019
  • Table 5.8 Acelity L.P. Inc.: Strategic Developments, 2015-2019
  • Table 5.9 Mölnlycke: Key Facts, 2019
  • Table 5.10 Mölnlycke: Strategic Developments, 2015-2019
  • Table 5.11 ConvaTec Group Plc: Key Facts, 2019
  • Table 5.12 ConvaTec Group Plc: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.13 ConvaTec Group Plc: Advanced Wound Care Revenue ($million), AGR (%) 2016-2018
  • Table 5.14 ConvaTec Group Plc: Strategic Developments, 2015-2019
  • Table 5.15 Coloplast A/S: Key Facts, 2018
  • Table 5.16 Coloplast A/S: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.17 Coloplast A/S: Wound & Skin Care Revenue ($million), AGR (%) 2016-2018
  • Table 5.18 Coloplast A/S: Strategic Developments, 2015-2019
  • Table 5.19 3M Company: Key Facts, 2019
  • Table 5.20 3M Company: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.21 3M Company: Strategic Developments, 2015-2018
  • Table 5.22 B. Braun Melsungen AG: Key Facts, 2019
  • Table 5.23 B. Braun Melsungen AG: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2017
  • Table 5.24 B. Braun Melsungen AG: Outpatient Revenue ($million), AGR (%) 2015-2017
  • Table 5.25 B. Braun Melsungen AG: Strategic Developments, 2015-2018
  • Table 5.26 BSN Medical GmbH: Key Facts, 2018
  • Table 5.27 BSN Medical GmbH: Strategic Developments, 2015-2018
  • Table 5.28 Cardinal Health, Inc.: Key Facts, 2019
  • Table 5.29 Cardinal Health, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.30 Cardinal Health, Inc.: Medical Segment Revenue ($million), AGR (%) 2016-2018
  • Table 5.31 Cardinal Health, Inc.: Strategic Developments, 2015-2019
  • Table 5.32 Generex Biotechnology Corp.: Key Facts, 2019
  • Table 5.33 Generex Biotechnology Corp.: Strategic Developments, 2015-2019
  • Table 5.34 Hill-Rom Holdings, Inc.: Key Facts, 2019
  • Table 5.35 Hill-Rom Holdings, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.36 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), AGR (%) 2016-2018
  • Table 5.37 Hill-Rom Holdings, Inc.: Strategic Developments, 2015-2018
  • Table 5.38 Hollister, Inc.: Key Facts, 2018
  • Table 5.39 Integra LifeSciences Holdings Corporation: Key Facts, 2019
  • Table 5.40 Integra LifeSciences Holdings Corporation: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.41 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), AGR (%) 2016-2018
  • Table 5.42 Integra LifeSciences Holdings Corporation: Strategic Developments, 2015-2018
  • Table 5.43 Lohmann & Rauscher GmbH & Co. Kg: Key Facts, 2018
  • Table 5.44 Lohmann & Rauscher GmbH & Co. Kg: Strategic Developments, 2015-2018
  • Table 5.45 Medline Industries, Inc.: Key Facts, 2018
  • Table 5.46 Medtronic PLC: Key Facts, 2018
  • Table 5.47 Medtronic PLC: Revenue ($million) and Revenue Shares (%) by Segment, 2018
  • Table 5.48 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), AGR (%) 2016-2018
  • Table 5.49 Medtronic PLC: Minimally Invasive Product Revenue ($million) and Revenue Shares (%), 2018
  • Table 5.50 Medtronic PLC: Strategic Developments, 2015-2018
  • Table 5.51 Organogenesis Inc.: Key Facts, 2018
  • Table 5.52 Organogenesis Inc.: Strategic Developments, 2015-2018
  • Table 5.53 PAUL HARTMANN AG: Key Facts, 2019
  • Table 5.54 PAUL HARTMANN AG: Revenue ($million) and Revenue Shares (%) by Segment, 2018
  • Table 5.55 PAUL HARTMANN AG: Wound Management Revenue ($million), AGR (%) 2017-2018
  • Table 5.56 Celularity, Inc.: Key Facts, 2019
  • Table 5.57 Celularity, Inc.: Strategic Developments, 2015-2018
  • Table 5.58 Johnson & Johnson: Key Facts, 2019
  • Table 5.59 Johnson & Johnson: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.60 Johnson & Johnson: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
  • Table 5.61 Johnson & Johnson: Wound Care/Other Revenue ($million), AGR (%) 2016-2018
  • Table 7.1 Top 20 Companies and Revenue, 2018 ($million)

List of Figures

  • Figure 4.1 Market share of key companies in advanced wound care market (%), 2018
  • Figure 4.2 Global Advanced Wound Care Market Revenue ($bn), 2018-2029
  • Figure 5.1 Smith & Nephew Plc.: Historical Revenues ($million, 2014-2018
  • Figure 5.2 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.3 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.4 Smith & Nephew Plc.: Revenue Shares (%) by Region, 2018
  • Figure 5.5 Smith & Nephew Plc: Advanced Wound Management Revenue ($million), 2016-2018
  • Figure 5.6 Smith & Nephew Plc.: Advanced Wound Management Product Revenue Shares (%), 2018
  • Figure 5.7 Mölnlycke : Historical Revenues ($million), 2014-2018
  • Figure 5.8 ConvaTec Group Plc: Historical Revenues ($million), 2014-2018
  • Figure 5.9 ConvaTec Group Plc: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.10 ConvaTec Group Plc: Revenue Shares (%) by Region, 2018
  • Figure 5.11 ConvaTec Group Plc: Advanced Wound Care Revenue Shares (%), 2016-2018
  • Figure 5.12 Coloplast A/S: Historical Revenues ($million), 2014-2018
  • Figure 5.13 Coloplast A/S: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.14 Coloplast A/S: Revenue Shares (%) by Region, 2018
  • Figure 5.15 Coloplast A/S: Wound & Skin Care Revenue ($million), 2016-2018
  • Figure 5.16 3M Company: Historical Revenues ($million), 2014-2018
  • Figure 5.17 3M Company: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.18 3M Company: Revenue Shares (%) by Region, 2018
  • Figure 5.19 B. Braun Melsungen AG: Historical Revenues ($million), 2013-2017
  • Figure 5.20 B. Braun Melsungen AG: Revenue Shares (%) by Reporting Segment, 2017
  • Figure 5.21 B. Braun Melsungen AG: Revenue Shares (%) by Region, 2017
  • Figure 5.22 B. Braun Melsungen AG: Outpatient Revenue ($million), 2015-2017
  • Figure 5.23 Cardinal Health, Inc.: Historical Revenues ($million), 2014-2018
  • Figure 5.24 Cardinal Health, Inc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.25 Cardinal Health, Inc.: Revenue Shares (%) by Region, 2018
  • Figure 5.26 Cardinal Health, Inc.: Medical Segment Revenue ($million), 2016-2018
  • Figure 5.27 Hill-Rom Holdings, Inc.: Historical Revenues ($million), 2014-2018
  • Figure 5.28 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.29 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Region, 2018
  • Figure 5.30 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), 2016-2018
  • Figure 5.31 Integra LifeSciences Holdings Corporation: Historical Revenues ($million), 2014-2018
  • Figure 5.32 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.33 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Region, 2018
  • Figure 5.34 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), 2016-2018
  • Figure 5.35 Medtronic PLC: Historical Revenues ($million), 2014-2018
  • Figure 5.36 Medtronic PLC: Revenue Shares (%) by Segment, 2018
  • Figure 5.37 Medtronic PLC: Revenue Shares (%) by Product Type, 2018
  • Figure 5.38 Medtronic PLC: Revenue Shares (%) by Region, 2017
  • Figure 5.39 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), 2016-2018
  • Figure 5.40 Medtronic PLC: Minimally Invasive Product Revenue Shares (%), 2018
  • Figure 5.42 PAUL HARTMANN AG: Revenue Shares (%) by Product Type, 2018
  • Figure 5.43 PAUL HARTMANN AG: Revenue Shares (%) by Region, 2018
  • Figure 5.44 PAUL HARTMANN AG: Wound Management Revenue ($million), 2017-2018
  • Figure 5.45 PAUL HARTMANN AG: Wound Management Revenue by Region($million), 2018
  • Figure 5.46 Johnson & Johnson: Historical Revenues ($million), 2014-2018
  • Figure 5.47 Johnson & Johnson: Revenue Shares (%) by Reporting Segment, 2018
  • Figure 5.48 Johnson & Johnson: Revenue Shares (%) by Product, 2018
  • Figure 5.49 Johnson & Johnson: Revenue Shares (%) by Region, 2018
  • Figure 5.50 Johnson & Johnson: Wound Care/Other Revenue ($million), 2016-2018
  • Figure 5.51 Johnson & Johnson: Wound Care/Other Revenue by Region ($million), 2018
  • Figure 6.1 SWOT Analysis of the Global Advanced Wound Care Market, 2019

List of Companies and Organizations Mentioned in the Report:

  • 3M Company
  • Acelity L.P. Inc.
  • Alliqua BioMedical
  • Avista Capital Partners
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Celularity, Inc.
  • Center for Disease Control (CDC)
  • Codman Neurosurgery
  • Coloplast A/S
  • ConvaTec Group plc
  • Covidien Plc.
  • Crawford Healthcare
  • DeOst group
  • ER Squibb & Sons
  • FarrowMed
  • Food and Drug Administration (FDA)
  • Generex Biotechnology Corp.
  • GHD GesundHeits GMBH Deutschland
  • Healthpoint Biotheraputics
  • Hill-Rom Holdings, Inc.
  • Hollister Incorporated
  • Immodulon
  • Integra LifeSciences Holdings Corporation
  • International Diabetes Federation (IDF)
  • Johnson & Johnson
  • Johnson & Johnson
  • JoViPak
  • KCI
  • Lohmann & Rauscher GmbH & Co. Kg
  • Mediq
  • Medline Industries, Inc.
  • Medtronic PLC
  • Metasurg
  • Ministry of Health, Labour, and Welfare (MHLW)
  • Mölnlycke Health Care
  • Nordic Capital Partners
  • NuTech Medical
  • Olaregen Therapeutix Inc.
  • Organogenesis
  • PAUL HARTMANN AG
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Regentys Corporation
  • SastoMed GmbH.
  • Smith & Nephew
  • SNaP
  • Sorbion
  • Spiracur Inc.
  • Sundance Enterprises, Inc.
  • TEI Biosciences Inc.
  • TEI Medical Inc.
  • Terumo Corporation
  • The Harvard Drug Group (THDG)
  • Tissue Analytics
  • World Health Organisation (WHO)
  • Wright Therapy Products, Inc.